Vivan Life Sciences, a game changer in Pharma Industry

Tuesday, April 26, 2016 General News J E 4
VIVAN Life Sciences is Knowledge based innovative enterprise offering higher end level products in Pharmaceuticals and Life Sciences. We provide break through collaboration for the niche pharmaceutical products which enhance the capability and productivity performances of our customers and Business Associates in functions critical to their success. The meaning of Vivan is “full of life” and we believe in making products which are life changing. We offer our products through the below mentioned Strategic Business Units (SBUs). These Business Units operates independently with internal co-ordination and promotional alignment: • Pharmaceutical Manufacturing Unit (PMU) • Specialized Synthesis Unit (SSU) The above mentioned Strategic Business units cater broadly to Pharmaceutical and Life Sciences companies CROs (Contract Research Organizations) Clinical Research Companies and Speciality Chemicals Companies. We have collaborated with several Global companies on various projects and derived exceptional value to them on the projects which are important and critical to their success. We offer higher-end products in Pharmaceuticals and Life Sciences Our Esteemed Clientele consists of Pharmaceuticals and Life Sciences Companies Global Generic companies CROs (Contract Research Organizations) Clinical Research and Speciality Chemical Companies. We take pride in playing an important role in the success of their Crucial projects. there by improving the capability & productivity performances of our clientele. This enables in deriving exceptional value to the Projects critical to their success.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
New Review of the LenSx Laser - A Review of Curren...
Sinovac Files 2015 Annual Report on Form 20-F